2019
DOI: 10.1016/j.ijrobp.2019.06.366
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)

Abstract: Furthermore, within the haploidentical cohort, our use of 3 Gy x 1 was associated with higher cure rates than previously published studies which had utilized 2 Gy x 1.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles